Novartis acquires IFM Tre

Novartis will add to its broad portfolio of immunomodulatory medicines with the planned acquisition of IFM Tre, a subsidiary of IFM Therapeutics LLC focused...

GHO Capital acquires Sterling Pharma Solutions

European specialist investor in healthcare, GHO Capital, has acquired a majority stake in Sterling Pharma Solutions, a specialist in complex and difficult to manufacture...

Healthtech M&A and IPO Activity

The latest Healthtech M&A and IPO Activity Market Report from Hampleton Partners has revealed a final count of almost 100 deals in the healthtech...

DoseCare acquires Biodose

DoseCare announces its acquisition of Biodose, the UK’s only monitored dosage system (MDS) that accommodates liquid and solid medication. Biodose, a medication management solution,...

UK pharma pressing ahead with M&As in 2019

The UK pharmaceutical industry is pressing ahead with M&A activity and is geared to weather any disruption due to Brexit, according to the results...

Sanofi and Denali join forces on inflammatory disease drugs

Sanofi plans to collaborate with Denali Therapeutics Inc. on the development of multiple molecules with the potential to be neurological and systemic inflammatory disease...

AstraZeneca divests rights for Nexium and Vimovo to Grünenthal

AstraZeneca has agreed to divest the prescription medicine rights for Nexium in Europe, as well as the global rights (excluding the US and Japan)...

Mundipharma acquires biosimilars development company

The Mundipharma global network of independent associated companies has added development capabilities to its biosimilars platform with the purchase of biosimilars development company, Cinfa...

BioIVT acquires CTLS a UK blood donor facility

BioIVT acquires Clinical Trials Laboratory Services (CTLS), a donor centre and laboratory based in London, UK. BioIVT, is a provider of research models and...

Tusk Therapeutics to be acquired by Roche

Tusk Therapeutics Ltd has been acquired by Roche. Tusk was founded in 2014 by Droia Oncology Ventures, Tusk’s majority shareholder. Under the terms of...

Latest articles

Dr Harry Destecroix of Ziylo wins 2019 Pharmaceutical Industry Network Group Innovation Award

Biotech leader wins PING Innovation Award 2019

Dr Harry Destecroix of Ziylo has won the 2019 Pharmaceutical Industry Network Group (PING) Innovation Award, hosted by pharma and life sciences specialist law...
NICE recommend funding for Spinraza

NICE recommend funding for Spinraza for spinal muscular atrophy

The National Institute for Health and Care Excellence (NICE) has recommended funding for Spinraza (nusinersen) on the National Health Service (NHS). The positive recommendation, subject to...
Data from Symbicort Turbuhaler Novel START trial among 73 AstraZeneca abstracts accepted for presentation at ATS

New data from Novel START trial accepted for presentation

New data from the Symbicort Turbuhaler (budesonide/formoterol) Novel START trial is among 73 AstraZeneca abstracts accepted for oral or poster presentation at the American...

Popular articles

pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...
new migraine data for Aimovig presented by Novartis

Novartis presents new migraine data for Aimovig®▼ (erenumab)

Novartis presents new migraine data for Aimovig®▼ (erenumab) demonstrating sustained efficacy to 52 weeks. Novartis has announced that new data from two follow-up studies of...
Data from Symbicort Turbuhaler Novel START trial among 73 AstraZeneca abstracts accepted for presentation at ATS

New data from Novel START trial accepted for presentation

New data from the Symbicort Turbuhaler (budesonide/formoterol) Novel START trial is among 73 AstraZeneca abstracts accepted for oral or poster presentation at the American...

Top 5 R&D hubs in the UK

Read this cover story in the June issue of Pf Magazine here.    Join us on a tour of inspirational research and development centres. ...
Dr Harry Destecroix of Ziylo wins 2019 Pharmaceutical Industry Network Group Innovation Award

Biotech leader wins PING Innovation Award 2019

Dr Harry Destecroix of Ziylo has won the 2019 Pharmaceutical Industry Network Group (PING) Innovation Award, hosted by pharma and life sciences specialist law...